ASTRAZENECA has vowed to stop paying travel expenses for doctors attending international medical conferences.
In a bid to clamp down on a practice which has been criticised as marketing, the Anglo-Swedish pharmaceutical group says it will now only fund local medical education programmes round the world,
Chief executive David Brennan told the FT: “The appearance of conflict is a concern. Our medicines stand on their own merits.”
Other firm have tried to clean up the industry’s image by not paying for business class travel or luxurious conference venues but AstraZeneca has gone even further by imposing a cross-border ban.